skip to Main Content

Dr. Saif on Recommendations for Germline Testing in Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Wasif M. Saif, MD, MBBS, deputy physician in chief, director of medical oncology, Northwell Health Cancer Institute, professor of medical oncology, Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, discusses recommendations for germline testing in patients with pancreatic cancer.

The National Comprehensive Cancer Network recommends that all patients with pancreatic cancer be tested for germline mutations, according to Saif. Moreover, it has been advised that targeted agents can benefit patients with somatic mutations, as well, Saif says. Read more . . . 

Back To Top